We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$14.5B
AUM Growth
+$1.96B
Cap. Flow
+$582M
Cap. Flow %
4.02%
Top 10 Hldgs %
31.8%
Holding
146
New
31
Increased
52
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$319M
2
IMMU
Immunomedics Inc
IMMU
+$296M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$216M
4
NYT icon
New York Times
NYT
+$130M
5
HLT icon
Hilton Worldwide
HLT
+$129M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$456M
2
WUBA
58.com Inc
WUBA
+$268M
3
CRM icon
Salesforce
CRM
+$181M
4
QGEN icon
Qiagen
QGEN
+$123M
5
CZR
Caesars Entertainment Corporation
CZR
+$97.2M

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Communication Services 17.58%
3 Technology 8.21%
4 Financials 7.39%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
26
New Oriental
EDU
$8.98B
$205M 1.42%
1,368,778
+737,778
+117% +$107M
BX icon
27
Blackstone
BX
$110B
$200M 1.38%
3,829,336
+1,061,017
+38% +$56.8M
IOVA icon
28
Iovance Biotherapeutics
IOVA
$2.87B
$196M 1.36%
5,955,000
-582,500
-9% -$17.9M
ASND icon
29
Ascendis Pharma A/S
ASND
$16.8B
$193M 1.33%
1,250,000
+110,000
+10% +$15.8M
BABA icon
30
Alibaba
BABA
$308B
$180M 1.25%
612,585
-314,115
-34% -$82.8M
GD icon
31
General Dynamics
GD
$106B
$177M 1.22%
1,277,107
+125,626
+11% +$18.6M
CRM icon
32
Salesforce
CRM
$158B
$176M 1.21%
698,315
-827,333
-54% -$181M
ALNY icon
33
Alnylam Pharmaceuticals
ALNY
$29.3B
$175M 1.21%
1,200,000
+150,000
+14% +$21.3M
MYOK
34
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$167M 1.16%
1,225,000
+350,000
+40% +$37.2M
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
$156M 1.08%
5,097,546
+997,546
+24% +$30.1M
TRU icon
36
TransUnion
TRU
$15.3B
$153M 1.06%
1,814,132
+621,385
+52% +$53.7M
EQIX icon
37
Equinix
EQIX
$103B
$152M 1.05%
200,164
-67,433
-25% -$51M
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$145M 1.01%
875,000
+225,000
+35% +$30.8M
HLT icon
39
Hilton Worldwide
HLT
$71.5B
$132M 0.91%
+1,545,877
New +$129M
PLYA
40
DELISTED
Playa Hotels & Resorts
PLYA
$128M 0.89%
30,606,930
– –
FATE icon
41
Fate Therapeutics
FATE
$326M
$125M 0.86%
3,125,000
-375,000
-11% -$13.1M
HWM icon
42
Howmet Aerospace
HWM
$112B
$121M 0.83%
7,210,388
+6,011,202
+501% +$100M
LVGO
43
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$116M 0.8%
+830,000
New +$101M
BMY.RT
44
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$99.2M 0.69%
44,073,000
-127,000
-0.3% -$363K
CI icon
45
Cigna
CI
$74.6B
$85.1M 0.59%
502,231
+2,231
+0.4% +$393K
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.77B
$84.3M 0.58%
600,000
+75,000
+14% +$11.4M
MXIM
47
DELISTED
Maxim Integrated Products
MXIM
$83.2M 0.58%
+1,230,000
New +$83.2M
ENTA icon
48
Enanta Pharmaceuticals
ENTA
$400M
$81.3M 0.56%
1,775,000
+25,000
+1% +$1.21M
NVCR icon
49
NovoCure
NVCR
$1.91B
$80.7M 0.56%
+725,000
New +$58M
KYNB
50
Kyntra Bio
KYNB
$29.4M
$76.1M 0.53%
74,000
+9,000
+14% +$9.68M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Farallon Capital Management held 146 positions worth $14.5B, up 16% from $12.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management deployed $582M of net new capital in Q3 2020, opening 31 new positions and adding to 52 existing holdings. Its largest new stake was Boston Scientific: 8,275,919 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Salesforce, an estimated $181M trimmed.

  • Farallon Capital Management's largest Q3 2020 buy was Boston Scientific: 8,275,919 shares worth $316M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q3 2020, an estimated $216M increase.
  • Farallon Capital Management's biggest Q3 2020 reduction was Salesforce, cutting an estimated $181M.
  • Farallon Capital Management fully exited People Inc in Q3 2020, selling an estimated $456M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $14.5B portfolio in Q3 2020.
  • Farallon Capital Management opened 31 new positions and closed 24 in Q3 2020.
  • Farallon Capital Management's portfolio value rose 16% quarter-over-quarter to $14.5B.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.